US$ 28.70
10mg semaglutide vial semaglutide 10 mg vial Semaglutide
Description
Mounjaro's FDA approval is for type 2 diabetes, not chronic weight management

Waiting 2 weeks brings residual semaglutide below 25% of the last dose, which substantially reduces GLP-1 receptor occupation when tirzepatide is introduced

When does insurance cover injectables

Diabetic patients: Individuals with type 2 diabetes who are prescribed semaglutide as part of their diabetes management regimen can benefit from monitoring their semaglutide levels to ensure the medication is effectively controlling their blood sugar levels

Am J Clin Nutr 2001

The drug is one variable
